Business
Hikma announces CEO change and Board appointment
Hikma Pharmaceuticals Plc announced that Riad Mishlawi is stepping down as CEO and from the Board of Directors, with Executive Chairman Said Darwazah assuming CEO responsibilities immediately. Chief Financial Officer Khalid Nabilsi will join the Board and take on additional management duties. The company confirmed that group guidance for 2025 remains unchanged from its November 6th trading update, and full-year results will be reported on February 26, 2026. Disclaimer*
About this update from Hikma Pharmaceuticals Plc
[{"type":"text","content":"\n\nHikma announces CEO change and Board appointment\n \nThis announcement contains inside information\n \nLondon, 15 December 2025 - Hikma Pharmaceuticals PLC (Hikma) announces that Riad Mishlawi is today stepping down as Chief Executive Officer (CEO) and from Hikma's Board of Directors by mutual agreement. \nSaid Darwazah, Hikma's Executive Chairman and former CEO, will assume all CEO responsibilities with immediate effect. In addition, Khalid Nabilsi, Hikma's Chief Financial Officer, will join Hikma's Board of Directors and take on additional management responsibilities to further strengthen the Group's focus on delivering its strategic plans.\nSaid Darwazah said: \"I would like to thank Riad for his contributions over his long career at Hikma and we wish him well for the future. I look forward to continuing to work closely with Hikma's Executive Committee and with Khalid in his expanded role to deliver on our strategic plans.\"\nVictoria Hull, Hikma's Senior Independent Director said: \"The Board is confident in Hikma's future growth prospects under the experienced leadership of Said, supported by Hikma's talented global team. We will be launching a search for a new CEO in due course.\"\nRiad Mishlawi said: \"I'd like to thank Said and all my Hikma colleagues. It has been an honour to work alongside you and, as I move into retirement, I wish you continued growth and every success.\"\nGroup guidance for 2025 remains unchanged from the 6 November 2025 trading update and Hikma will report its 2025 full year results on 26 February 2026.\n \nNotes:\n \nThe person responsible for the release of this announcement on behalf of Hikma is Helen Middlemist (Company Secretary).\n \nHikma confirms there is no information required to be disclosed in relation to Khalid Nabilsi's appointment as a director pursuant to UK Listing Rule 6.4.8R.\n \nDetails of remuneration arrangements in relation to Riad Mishlawi's departure from Hikma will be disclosed on Hikma's website in accordance with section 430(2B) of the Companies Act 2006.\n \n-- ENDS --\n \nEnquiries:\nHikma (Investors) &nb...